130 related articles for article (PubMed ID: 27119723)
1. Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease.
Takahashi C; Akachi Y; Ogawa N; Moriguchi K; Asaka T; Tanemura M; Kawashima Y; Yamamoto H
Med Mol Morphol; 2017 Mar; 50(1):9-16. PubMed ID: 27119723
[TBL] [Abstract][Full Text] [Related]
2. Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid.
Takahashi C; Ogawa N; Kawashima Y; Yamamoto H
Microscopy (Oxf); 2015 Jun; 64(3):169-80. PubMed ID: 25757698
[TBL] [Abstract][Full Text] [Related]
3. A microscopy method for scanning transmission electron microscopy imaging of the antibacterial activity of polymeric nanoparticles on a biofilm with an ionic liquid.
Takahashi C; Muto S; Yamamoto H
J Biomed Mater Res B Appl Biomater; 2017 Aug; 105(6):1432-1437. PubMed ID: 27086715
[TBL] [Abstract][Full Text] [Related]
4. Imaging of intracellular behavior of polymeric nanoparticles in Staphylococcus epidermidis biofilms by slit-scanning confocal Raman microscopy and scanning electron microscopy with energy-dispersive X-ray spectroscopy.
Takahashi C; Ueno K; Aoyama J; Adachi M; Yamamoto H
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1066-1074. PubMed ID: 28482470
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells.
Cheow WS; Chang MW; Hadinoto K
J Biomed Nanotechnol; 2010 Aug; 6(4):391-403. PubMed ID: 21323113
[TBL] [Abstract][Full Text] [Related]
6. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
7. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
[TBL] [Abstract][Full Text] [Related]
8. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
Mahmoud MY; Demuth DR; Steinbach-Rankins JM
J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
[TBL] [Abstract][Full Text] [Related]
9. Surface-Adaptive, Antimicrobially Loaded, Micellar Nanocarriers with Enhanced Penetration and Killing Efficiency in Staphylococcal Biofilms.
Liu Y; Busscher HJ; Zhao B; Li Y; Zhang Z; van der Mei HC; Ren Y; Shi L
ACS Nano; 2016 Apr; 10(4):4779-89. PubMed ID: 26998731
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.
Mohammadi G; Nokhodchi A; Barzegar-Jalali M; Lotfipour F; Adibkia K; Ehyaei N; Valizadeh H
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):39-44. PubMed ID: 21752610
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers with conjugated antimicrobials to eradicate pathogenic biofilms evaluated in murine in vivo and human ex vivo infection models.
Liu Y; Ren Y; Li Y; Su L; Zhang Y; Huang F; Liu J; Liu J; van Kooten TG; An Y; Shi L; van der Mei HC; Busscher HJ
Acta Biomater; 2018 Oct; 79():331-343. PubMed ID: 30172935
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis-like uptake of surface-modified drug nanocarriers into giant unilamellar vesicles.
Tahara K; Tadokoro S; Kawashima Y; Hirashima N
Langmuir; 2012 May; 28(18):7114-8. PubMed ID: 22515197
[TBL] [Abstract][Full Text] [Related]
14. Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori.
Lotfipour F; Valizadeh H; Milani M; Bahrami N; Ghotaslou R
Drug Res (Stuttg); 2016 Jan; 66(1):41-5. PubMed ID: 25919643
[TBL] [Abstract][Full Text] [Related]
15. Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm.
Iannitelli A; Grande R; Di Stefano A; Di Giulio M; Sozio P; Bessa LJ; Laserra S; Paolini C; Protasi F; Cellini L
Int J Mol Sci; 2011; 12(8):5039-51. PubMed ID: 21954343
[TBL] [Abstract][Full Text] [Related]
16. Optimization of ionic liquid-incorporated PLGA nanoparticles for treatment of biofilm infections.
Takahashi C; Hattori Y; Yagi S; Murai T; Takai C; Ogawa N; Tanemura M; Fuji M; Kawashima Y; Yamamoto H
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():78-83. PubMed ID: 30678968
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity.
Barros CHN; Hiebner DW; Fulaz S; Vitale S; Quinn L; Casey E
J Nanobiotechnology; 2021 Apr; 19(1):104. PubMed ID: 33849570
[TBL] [Abstract][Full Text] [Related]
18. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
Shaaban MI; Shaker MA; Mady FM
J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
[TBL] [Abstract][Full Text] [Related]
19. Auranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections.
Díez-Martínez R; García-Fernández E; Manzano M; Martínez Á; Domenech M; Vallet-Regí M; García P
Sci Rep; 2016 Jan; 6():19525. PubMed ID: 26776881
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
